09:37 AM EST - Microbix Biosystems Inc. : Announces the commercial launch of QAPs™ quality assessment products and availability of QUANTDx™ reference materials to support antigen or molecular tests for H3N2 strains of seasonal Influenza A. Microbix Biosystems Inc.
shares T.MBX are trading down $0.01 at $0.24.
